相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis
Eleonora Tavazzi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views
Tjalf Ziemssen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Radiologically Isolated Syndrome:10-YearRisk Estimate of a Clinical Event
Christine Lebrun-Frenay et al.
ANNALS OF NEUROLOGY (2020)
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Ludwig Kappos et al.
JAMA NEUROLOGY (2020)
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity
Anne-Laure Kaminsky et al.
JOURNAL OF NEUROLOGY (2020)
Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm
Bruce A. C. Cree et al.
CURRENT OPINION IN NEUROLOGY (2019)
Chronic inflammation in multiple sclerosis - seeing what was always there
Paul M. Matthews
NATURE REVIEWS NEUROLOGY (2019)
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies
Zhifeng Mao et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
FRONTIERS IN IMMUNOLOGY (2019)
Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis
Valerie J. Block et al.
JAMA NETWORK OPEN (2019)
Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
Sabina Luchetti et al.
ACTA NEUROPATHOLOGICA (2018)
Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease
Christina J. Azevedo et al.
ANNALS OF NEUROLOGY (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
New Insights into Multiple Sclerosis Clinical Course from the Topographical Model and Functional Reserve
Stephen C. Krieger et al.
NEUROLOGIC CLINICS (2018)
Cognition in multiple sclerosis: State of the field and priorities for the future
James F. Sumowski et al.
NEUROLOGY (2018)
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
Niels Bergsland et al.
NEUROIMAGE-CLINICAL (2018)
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study
David H. Miller et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Meningeal inflammation and cortical demyelination in acute multiple sclerosis
Ryan J. Bevan et al.
ANNALS OF NEUROLOGY (2018)
Ocrelizumab: a new milestone in multiple sclerosis therapy
Patricia Mulero et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Tertiary Lymphoid Structures: Autoimmunity Goes Local
Elena Pipi et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS)
Freya Corfield et al.
NEUROLOGY AND THERAPY (2018)
Cervical spinal cord atrophy An early marker of progressive MS onset
Burcu Zeydan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Molecular-based diagnosis of multiple sclerosis and its progressive stage
Christopher Barbour et al.
ANNALS OF NEUROLOGY (2017)
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
Orhun H. Kantarci et al.
ANNALS OF NEUROLOGY (2016)
What lies beneath grey matter atrophy in multiple sclerosis?
Declan T. Chard et al.
BRAIN (2016)
Defining secondary progressive multiple sclerosis
Johannes Lorscheider et al.
BRAIN (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Aging and multiple sclerosis
Shaik Ahmed Sanai et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Aging and multiple sclerosis
Shaik Ahmed Sanai et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Josa M. Frischer et al.
ANNALS OF NEUROLOGY (2015)
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15
Ludwig Kappos et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
Don H. Mahad et al.
LANCET NEUROLOGY (2015)
Multiple sclerosis-a quiet revolution
Richard M. Ransohoff et al.
NATURE REVIEWS NEUROLOGY (2015)
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis
Regina Schlaeger et al.
JAMA NEUROLOGY (2015)
Neurologists' accuracy in predicting cognitive impairment in multiple sclerosis
Kristoffer Romero et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Multiple sclerosis: Lessons from molecular neuropathology
Hans Lassmann
EXPERIMENTAL NEUROLOGY (2014)
Onset of secondary progressive phase and long-term evolution of multiple sclerosis
Antonio Scalfari et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
Lukas Haider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with 18F-PBR111 PET
Alessandro Colasanti et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195
Eero Rissanen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Composite end points to assess delay of disability progression by MS treatments
J. Zhang et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis
Ilana Katz Sand et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event
Darin T. Okuda et al.
PLOS ONE (2014)
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Maarten E. Witte et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
Impact of multiple sclerosis relapses on progression diminishes with time
H. Tremlett et al.
NEUROLOGY (2009)
分享论文
